Tysabri 64406-0008-01
Generic: Natalizumab
- Manufacturer
- Biogen Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 23, 2004
- Listing Expires
- December 31, 2026
- Application
- BLA125104
Need to source Tysabri? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Natalizumab | 300 mg/15mL |
Drug Class
Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]
Selected Package
64406-0008-01Selected1 VIAL, SINGLE-USE in 1 CARTON (64406-008-01) / 15 mL in 1 VIAL, SINGLE-USE